Pamela Stephenson
CIK 1767650 · Chief Commercial Officer · last filed 2026-02-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.51M
Companies
3
Total Filings
39
Lifetime Open-Market Net
-$805.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRON | Chief Commercial Officer | 80,998 | $67.99 | $5.51M | -$518.9K | 5 | 2026-02-17 |
| Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Director | 47,824 | $1.30 | $62.2K | -$80 | 7 | 2023-10-11 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Chief Commercial Officer | 0 | $44.15 | $0 | -$286.4K | 27 | 2023-03-02 |
Recent Filings · Page 4 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-12-29 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −460 | -$18.0K | EDGAR |
| 2020-09-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −451 | -$15.0K | EDGAR |
| 2020-06-26 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −397 | -$12.2K | EDGAR |
| 2020-06-11 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-25 | ALBIREO PHARMA, INC. (ALBO) Delisted | Sell (S) | −1,785 | -$31.4K | EDGAR |
| 2020-01-23 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-13 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-27 | ALBIREO PHARMA, INC. (ALBO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2019-02-20 | Zynerba Pharmaceuticals, Inc. (ZYNE) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–39 of 39
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.